The Impact of Tumor Infiltrating Lymphocytes Densities and Ki67 Index on Residual Breast Cancer Burden following Neoadjuvant Chemotherapy

Figure 4

A guidance plan to define whether a breast cancer patient is candidate for neoadjuvant chemotherapy or not.